Verrica Pharmaceuticals Inc at Cowen Health Care Conference Transcript
My name is Stacy Ku, one of the biopharma analysts, and I'm here with my colleague, Georgi Yordanov. I'd like to welcome Ted White, CEO of Verrica Pharmaceuticals; and Joe Bonaccorso, the Chief Commercial Officer to our fireside chat. Thank you so much for joining us today.
Thank you.
So we're very excited to discuss the potential and impending launch of YCANTH in July for molluscum contagiosum. I think you had the NDA resubmission last week. And with that, we'll dive right into Q&A.
Questions & Answers
So for those that are not familiar, can you just very broadly describe your product, VP-102 or YCANTH and then provide some brief background on molluscum contagiosum?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
